---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-018385"
form_type: "8-K"
ticker: "KPTI"
cik: "0001503802"
company_name: "Karyopharm Therapeutics Inc."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T04:39:48.899514+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Karyopharm grants retention equity awards: 412,500 stock options and 206,250 RSUs to three executives

## Summary
- Named executives Sohanya Chang, Stuart Poulton, and Reshma Rangwala each receive 137,500 options and 68,750 RSUs, effective Feb 28, 2025.
- Options vest 25% on first anniversary, then monthly over 4 years; RSUs vest 50% on each of two consecutive anniversaries.
- Full acceleration of awards if termination without cause or for good reason occurs within one year after a change-in-control event.
- Exercise price of options equals the closing stock price on the Nasdaq on the grant date.

## SEC filing metadata
- accession: 0001193125-25-018385
- form_type: 8-K
- ticker: KPTI
- cik: 0001503802
- company_name: Karyopharm Therapeutics Inc.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1503802/000119312525018385/0001193125-25-018385-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1503802/000119312525018385/d914351d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-018385
- JSON: https://secwatch.observer/filing/0001193125-25-018385.json
- Plain text: https://secwatch.observer/filing/0001193125-25-018385.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.